Skip to main content
Journal cover image

Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.

Publication ,  Journal Article
Malone, DC; Ramsey, SD; Patrick, DL; Johnson, FR; Mullins, CD; Roberts, MS; Willke, RJ; Marshall, DA
Published in: Value Health
April 2020

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s "Good Practices Task Force" reports are highly cited, multistakeholder perspective expert guidance reports that reflect international standards for health economics and outcomes research (HEOR) and their use in healthcare decision making. In this report, we discuss the criteria, development, and evaluation/consensus review and approval process for initiating a task force. The rationale for a task force must include a justification, including why this good practice guidance is important and its potential impact on the scientific community. The criteria include: (1) necessity (why is this task force required?); (2) a methodology-oriented focus (focus on research methods, approaches, analysis, interpretation, and dissemination); (3) relevance (to ISPOR's mission and its members); (4) durability over time; (5) broad applicability; and 6) an evidence-based approach. In addition, the proposal must be a priority specifically for ISPOR. These reports are valuable to researchers, academics, students, health technology assessors, medical technology developers and service providers, those working in other commercial entities, regulators, and payers. These stakeholder perspectives are represented in task force membership to ensure the report's overall usefulness and relevance to the global ISPOR membership. We hope that this discussion will bring transparency to the process of initiating, approving, and producing these task force reports and encourage participation from a diverse range of experts within and outside ISPOR.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Value Health

DOI

EISSN

1524-4733

Publication Date

April 2020

Volume

23

Issue

4

Start / End Page

409 / 415

Location

United States

Related Subject Headings

  • Research Report
  • Research Design
  • Outcome Assessment, Health Care
  • Internationality
  • Humans
  • Health Policy & Services
  • Evidence-Based Practice
  • Economics, Pharmaceutical
  • Advisory Committees
  • 4407 Policy and administration
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Malone, D. C., Ramsey, S. D., Patrick, D. L., Johnson, F. R., Mullins, C. D., Roberts, M. S., … Marshall, D. A. (2020). Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report. Value Health, 23(4), 409–415. https://doi.org/10.1016/j.jval.2020.03.001
Malone, Daniel C., Scott D. Ramsey, Donald L. Patrick, F Reed Johnson, C Daniel Mullins, Mark S. Roberts, Richard J. Willke, and Deborah A. Marshall. “Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.Value Health 23, no. 4 (April 2020): 409–15. https://doi.org/10.1016/j.jval.2020.03.001.
Malone DC, Ramsey SD, Patrick DL, Johnson FR, Mullins CD, Roberts MS, et al. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report. Value Health. 2020 Apr;23(4):409–15.
Malone, Daniel C., et al. “Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.Value Health, vol. 23, no. 4, Apr. 2020, pp. 409–15. Pubmed, doi:10.1016/j.jval.2020.03.001.
Malone DC, Ramsey SD, Patrick DL, Johnson FR, Mullins CD, Roberts MS, Willke RJ, Marshall DA. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report. Value Health. 2020 Apr;23(4):409–415.
Journal cover image

Published In

Value Health

DOI

EISSN

1524-4733

Publication Date

April 2020

Volume

23

Issue

4

Start / End Page

409 / 415

Location

United States

Related Subject Headings

  • Research Report
  • Research Design
  • Outcome Assessment, Health Care
  • Internationality
  • Humans
  • Health Policy & Services
  • Evidence-Based Practice
  • Economics, Pharmaceutical
  • Advisory Committees
  • 4407 Policy and administration